Fluorescent self-reporting theranostic platforms for tumour therapy: from cytotoxin release monitoring to therapeutic feedback evaluation
Source abstract
Abstract
Controlled drug release, which enables targeted drug delivery, enhances selectivity and safety, and holds broad application prospects in precision tumour therapy, is frequently limited by unpredictable cytotoxic release and variable therapeutic effects. To address this challenge, fluorescent self-reporting theranostic platforms (FSRTPs) have emerged as a promising approach, enabling real-time monitoring of drug release dynamics and therapeutic efficacy. This paper reviews fluorescence single-/dual-mode imaging-guided controlled-release therapeutics developed in recent years, highlighting their design rationales, imaging strategies, and biological applications. In addition, the characteristics of FSRTPs are critically compared across different therapeutic modalities from the dual perspectives of cytotoxin-release monitoring and therapeutic-feedback evaluation. A core focus is achieving high-resolution intracellular drug tracking and real-time biomarker sensing (e.g., Caspase-3) to enable prompt assessment of tumour cell apoptosis. Finally, we identify key bottlenecks in imaging depth, drug quantification, and pharmacokinetics and propose next-generation design principles to facilitate the clinical translation of adaptive, personalized cancer therapies.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photochromic and Fluorescence Chemistry · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China
School of Civil and Architectural Engineering, Jiangxi University of Water Resources and Electric Power, Nanchang 330099, China
Funding
Natural Science Foundation of Jiangxi Province · National Natural Science Foundation of China
References (100+)
Show source-provided references
1. Siegel · Ca- Cancer J. Clin. · 2025 · 75 · 10
2. Mateo · Nat. Med. · 2022 · 28 · 65810.1038/s41591-022-01717-2 ↗
3. Wang · Cancers · 2023 · 15 · 70110.3390/cancers15030701 ↗
4. Elzoghby · J. Controlled Release · 2012 · 157 · 16810.1016/j.jconrel.2011.07.031 ↗
5. Mikhail · Adv. Drug Delivery Rev. · 2023 · 202 · 11508310.1016/j.addr.2023.115083 ↗
6. Shi · Adv. Drug Delivery Rev. · 2023 · 199 · 11490410.1016/j.addr.2023.114904 ↗
7. Li · Adv. Mater. · 2013 · 25 · 438610.1002/adma.201300875 ↗
8. Kenchegowda · Molecules · 2021 · 27 · 14610.3390/molecules27010146 ↗
9. Chen · Acta Biomater. · 2017 · 51 · 37410.1016/j.actbio.2016.12.004 ↗
10. Shi · Biomaterials · 2014 · 35 · 584710.1016/j.biomaterials.2014.03.042 ↗
11. Ni · Chin. Chem. Lett. · 2017 · 28 · 134510.1016/j.cclet.2017.04.024 ↗
12. Shoaib · Nanotechnol. Rev. · 2024 · 13 · 110.1515/ntrev-2024-0023 ↗
13. Wu · Nanomedicine · 2014 · 10 · 29710.1016/j.nano.2013.08.008 ↗
14. Hou · Chem. Eng. J. · 2021 · 416 · 12903710.1016/j.cej.2021.129037 ↗
15. Sun · Bioconjugate Chem. · 2020 · 31 · 101210.1021/acs.bioconjchem.0c00082 ↗
16. Shen · Front. Bioeng. Biotechnol. · 2020 · 8 · 38110.3389/fbioe.2020.00381 ↗
17. Xiang · J. Controlled Release · 2022 · 348 · 44410.1016/j.jconrel.2022.06.007 ↗
18. Lee · Prog. Mater. Sci. · 2023 · 135 · 10108710.1016/j.pmatsci.2023.101087 ↗
19. Singh · ACS Appl. Bio Mater. · 2020 · 3 · 221810.1021/acsabm.0c00050 ↗
20. Patel · Mater. Horiz. · 2019 · 6 · 43410.1039/C8MH00966J ↗
21. Singh · ACS Appl. Mater. Interfaces · 2017 · 9 · 1030910.1021/acsami.6b16505 ↗
22. Qiao · Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnol. · 2019 · 11 · e1527
23. Ten Hagen · Commun. Biol · 2021 · 4 · 92010.1038/s42003-021-02428-z ↗
24. Phillips · Antioxid. Redox Signal. · 2014 · 21 · 78610.1089/ars.2013.5728 ↗
25. Rosenblum · Nat. Commun. · 2018 · 9 · 141010.1038/s41467-018-03705-y ↗
26. Baghban · Cell Commun. Signaling · 2020 · 18 · 5910.1186/s12964-020-0530-4 ↗
27. Bhat · Cancer Metastasis Rev. · 2024 · 43 · 19710.1007/s10555-024-10172-z ↗
28. Riboldi · Lancet Oncol. · 2012 · 13 · e38310.1016/S1470-2045(12)70243-7 ↗
29. Yang · J. Mater. Chem. B · 2025 · 13 · 113310.1039/D4TB01867B ↗
30. Stuker · Pharmaceutics · 2011 · 3 · 22910.3390/pharmaceutics3020229 ↗
31. Luo · Theranostics · 2017 · 7 · 124510.7150/thno.18187 ↗
32. Sharma · Chem. Rev. · 2024 · 124 · 269910.1021/acs.chemrev.3c00778 ↗
33. Chong · Acc. Chem. Res. · 2019 · 52 · 305110.1021/acs.accounts.9b00356 ↗
34. Yang · Talanta · 2023 · 259 · 12449310.1016/j.talanta.2023.124493 ↗
35. Yang · Anal. Chem. · 2023 · 95 · 1198810.1021/acs.analchem.3c01659 ↗
36. Zhang · Adv. Ther. · 2020 · 3 · 200011410.1002/adtp.202000114 ↗
37. Sun · Aggregate · 2022 · 3 · e28210.1002/agt2.282 ↗
38. Wang · ACS Sens. · 2023 · 8 · 473710.1021/acssensors.3c01824 ↗
39. Zheng · Nanophotonics · 2019 · 8 · 39110.1515/nanoph-2018-0219 ↗
40. Yu · Biomaterials · 2025 · 313 · 12276510.1016/j.biomaterials.2024.122765 ↗
41. Tao · Adv. Funct. Mater. · 2023 · 33 · 230324010.1002/adfm.202303240 ↗
42. Brito · Theranostics · 2021 · 11 · 870610.7150/thno.57004 ↗
43. Zhang · Colloids Surf., B · 2018 · 170 · 16310.1016/j.colsurfb.2018.06.008 ↗
44. Kong · Theranostics · 2018 · 8 · 80010.7150/thno.21577 ↗
45. Lee · Chem. Soc. Rev. · 2018 · 47 · 2810.1039/C7CS00557A ↗
46. Gong · Dyes Pigm. · 2020 · 173 · 10789310.1016/j.dyepig.2019.107893 ↗
47. Attri · Mol. Pharm. · 2021 · 18 · 12410.1021/acs.molpharmaceut.0c00730 ↗
48. Jirvankar · Gels · 2024 · 10 · 53510.3390/gels10080535 ↗
49. Li · Med. Res. Rev. · 2023 · 43 · 57010.1002/med.21932 ↗
50. Li · Small · 2022 · 18 · e220564710.1002/smll.202205647 ↗
51. Kong · Theranostics · 2018 · 8 · 80010.7150/thno.21577 ↗
52. Hak · Photodiagnosis Photodyn. Ther. · 2021 · 33 · 10220510.1016/j.pdpdt.2021.102205 ↗
53. Niculescu · Appl. Sci. · 2021 · 11 · 362610.3390/app11083626 ↗
54. Karges · Angew. Chem., Int. Ed. · 2022 · 61 · e20211223610.1002/anie.202112236 ↗
55. Zhao · Chem. Soc. Rev. · 2021 · 50 · 418510.1039/D0CS00173B ↗
56. Xiong · Coord. Chem. Rev. · 2024 · 510 · 21586310.1016/j.ccr.2024.215863 ↗
57. Lan · Adv. Healthcare Mater. · 2019 · 8 · e190013210.1002/adhm.201900132 ↗
58. Wang · Chem. Sci. · 2019 · 11 · 129910.1039/C9SC04875H ↗
59. Wang · J. Am. Chem. Soc. · 2023 · 145 · 1309910.1021/jacs.3c01666 ↗
60. Li · Mater. Horiz. · 2023 · 10 · 573410.1039/D3MH01244A ↗
61. Chen · Nat. Commun. · 2024 · 15 · 693510.1038/s41467-024-51253-5 ↗
62. Xie · Int. J. Mol. Sci. · 2024 · 25 · 413910.3390/ijms25084139 ↗
63. Huang · Acc. Chem. Res. · 2017 · 50 · 252910.1021/acs.accounts.7b00294 ↗
64. Li · Int. J. Mol. Sci. · 2022 · 23 · 790910.3390/ijms23147909 ↗
65. Chu · Nat. Rev. Cancer · 2014 · 14 · 19910.1038/nrc3672 ↗
66. Hannon · Adv. Ther. · 2021 · 4 · 2000294
67. Sun · Biomaterials · 2019 · 201 · 4210.1016/j.biomaterials.2019.02.014 ↗
68. Karimi · ACS Appl. Mater. Interfaces · 2016 · 8 · 2110710.1021/acsami.6b00371 ↗
69. Overchuk · ACS Nano · 2023 · 17 · 797910.1021/acsnano.3c00891 ↗
70. Qiao · Biosens. Bioelectron. · 2016 · 85 · 40310.1016/j.bios.2016.04.070 ↗
71. Feng · Biomater. Sci. · 2022 · 10 · 185510.1039/D1BM01912K ↗
72. Wu · ACS Appl. Bio Mater. · 2019 · 2 · 266810.1021/acsabm.9b00344 ↗
73. Wang · J. Mater. Chem. B · 2020 · 8 · 103310.1039/C9TB02274K ↗
74. Ma · Sci. Adv. · 2020 · 6 · eabc5963
75. Liu · Chem. Eng. J. · 2023 · 452 · 13934510.1016/j.cej.2022.139504 ↗
76. Sun · Adv. Funct. Mater. · 2023 · 34 · 2304144
77. Qin · Small · 2018 · 14 · e180241710.1002/smll.201802417 ↗
78. Larionova · Oncoimmunology · 2019 · 8 · 159600410.1080/2162402X.2019.1596004 ↗
79. Tilsed · Front. Oncol. · 2022 · 12 · 96031710.3389/fonc.2022.960317 ↗
80. van den Boogaard · Cancers · 2022 · 14 · 62710.3390/cancers14030627 ↗
81. Behranvand · Cancer Immunol. Immunother. · 2022 · 71 · 50710.1007/s00262-021-03013-3 ↗
82. Wang · J. Controlled Release · 2018 · 290 · 5610.1016/j.jconrel.2018.10.009 ↗
83. Gil · J. Controlled Release · 2022 · 349 · 14310.1016/j.jconrel.2022.04.044 ↗
84. Yang · Adv. Drug Delivery Rev. · 2022 · 187 · 11439410.1016/j.addr.2022.114394 ↗
85. Zhao · Coord. Chem. Rev. · 2024 · 521 · 215424
86. Liu · Coord. Chem. Rev. · 2022 · 468 · 214418
87. Yao · Chem. Rev. · 2014 · 114 · 613010.1021/cr200359p ↗
88. Kabir · Biology · 2022 · 11 · 113510.3390/biology11081135 ↗
89. Roy · Adv. Drug Delivery Rev. · 2023 · 197 · 11482110.1016/j.addr.2023.114821 ↗
90. Gao · Chem. Soc. Rev. · 2017 · 46 · 223710.1039/C6CS00908E ↗
91. Wang · Biomaterials · 2017 · 139 · 13910.1016/j.biomaterials.2017.06.002 ↗
92. Zhang · ACS Appl. Mater. Interfaces · 2018 · 10 · 779810.1021/acsami.7b18438 ↗
93. Li · ACS Appl. Mater. Interfaces · 2020 · 12 · 3243210.1021/acsami.0c08336 ↗
94. Kayal · ACS Appl. Bio Mater. · 2024 · 7 · 581010.1021/acsabm.4c00878 ↗
95. Liu · Chem. Commun. · 2025 · 651810.1039/D5CC00695C ↗
96. Jogalekar · Front. Immunol. · 2022 · 13 · 92598510.3389/fimmu.2022.925985 ↗
97. Belete · Biologics · 2021 · 15 · 67
98. Qiu · Adv. Mater. · 2021 · 33 · e200618910.1002/adma.202006189 ↗
99. Liu · J. Nanobiotechnol. · 2021 · 19 · 44310.1186/s12951-021-01078-x ↗
100. Yao · View · 2022 · 3 · 110.1002/VIW.20200185 ↗